| Literature DB >> 32406366 |
Layla Lavallé1,2,3, Rémy Bation1,2,3,4, Clément Dondé1,2,3, Marine Mondino1,2,3, Jérome Brunelin1,2,3.
Abstract
BACKGROUND: Based on the observed clinical overlap between obsessive-compulsive disorder (OCD) and schizophrenia (SCZ), both conditions may share, at least in part, common cognitive underpinnings. Among the cognitive deficits that could be involved, it has been hypothesized that patients share a failure in their abilities to monitor their own thoughts (source monitoring), leading to confusion between what they actually did or perceived and what they imagined. Although little is known regarding source-monitoring performances in patients with OCD, numerous studies in patients with SCZ have observed a relationship between delusions and/or hallucinations and deficits in both internal source- and reality-monitoring abilities.Entities:
Keywords: Cognitive continuum; obsessive–compulsive disorder; schizophrenia; source-monitoring
Mesh:
Year: 2020 PMID: 32406366 PMCID: PMC7355175 DOI: 10.1192/j.eurpsy.2020.48
Source DB: PubMed Journal: Eur Psychiatry ISSN: 0924-9338 Impact factor: 5.361
Sociodemographic and clinical characteristics of the included population.
| OCD | SCZ | HC |
| |
|---|---|---|---|---|
| 32 | 38 | 29 | ||
| Age (years) | 42.75 ± 14.41 | 41.05 ± 6.57 | 40.45 ± 9.31 | 0.46 |
| Gender (F:M) | 22:10 | 18:20 | 20:9 | 0.10 |
| Educational level | 12.86 ± 2.82 | 12.21 ± 3.17 | 14.21 ± 2.93 | 0.03* |
| YBOCS-obsessions | 12.5 ± 3.42 | NA | NA | |
| YBOCS-compulsions | 12.21 ± 3.62 | NA | NA | |
| YBOCS-total | 24.72 ± 6.47 | NA | NA | |
| PANSS-positive | NA | 20.58 ± 4.79 | NA | |
| PANSS-negative | NA | 20.71 ± 5.15 | NA | |
| PANSS-total | NA | 77.71 ± 13.78 | NA | |
| Duration of illness | 22.3 ± 13.9 | 13.5 ± 7.8 | NA | |
| Second generation antipsychotics | 7.7% | 94.7% | NA | |
| First generation antipsychotics | 7.7% | 31.6% | NA | |
| Mood stabilizers | 0% | 10.5% | NA | |
| Selective serotonin reuptake inhibitors | 79.9% | 7.9% | NA | |
| Tricyclics | 15.4% | 2.6% | NA | |
| Serotonin-norepinephrine reuptake inhibitors | 0% | 5.3% | NA |
The results are given as the mean ± standard deviation.
Abbreviations: HC, healthy controls; OCD, obsessive–compulsive disorder; SCZ, schizophrenia.
Figure 1.Experimental procedures for reality-monitoring (right panel) and internal source-monitoring (left panel) assessments.
Figure 2.Comparison of internal source-monitoring types of correct responses between HC (dark gray bars), patients with OCD (light gray bars), and patients with SCZ (medium gray bars). SAY responses are measured as the number of correctly identified said words, IMA responses are measured as the number of correctly identified imagined words and NEW responses are measured as the number of correctly identified new words. The results are displayed as the mean ± standard deviation. ns, not significant. ***p < 0.001; **p < 0.01; *p < 0.05.
Figure 3.Comparison of reality-monitoring correct responses between HC (dark gray bars), patients with OCD (light gray bars), and patients with SCZ (medium gray bars). HEAR responses are measured as the number of correctly identified heard words, IMA responses are measured as the number of correctly identified imagined words, and NEW responses are measured as the number of correctly identified new words. The results are displayed as the mean ± standard deviation. ns, not significant. ***p < 0.001; **p < 0.01; *p < 0.05.